Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Democrats Offer Bill Aiming To Curb Bot Online Purchases

-Bloomberg

byBenzinga Newsdesk

November 29, 2021

1 minute read

-Bloomberg

EF Hutton Initiates Coverage On Jasper Therapeutics with Buy Rating, Announces Price Target of $4

By Benzinga Newsdesk

Today, 3:02 PM

EF Hutton analyst Michael King initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Buy rating and announces Price Target of $4.

JSPR

The Rise Of The Cannabis Beverage: An Analysis

By Sumit Mehta

Today, 3:02 PM

Article via Mazakali.

CGC

‘The Black Swan’ Author Defends Fed And Banking System Amid SVB Collapse: ‘Technologists…Way Too Ignorant’

By Shanthi Rexaline

Today, 3:02 PM

Nassim Nicholas Taleb, a Lebanese-American options trader and strategist who is more popular for his book “The Black Swan: The Impact of the Highly Improbable,” voiced his support for the Federal Reserve in a series of tweets in the

SIVB

Oppenheimer Downgrades NeuBase Therapeutics to Perform

By Benzinga Newsdesk

Today, 3:02 PM

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.

NBSE

Democrats Offer Bill Aiming To Curb Bot Online Purchases

Related Posts

EF Hutton Initiates Coverage On Jasper Therapeutics with Buy Rating, Announces Price Target of $4

The Rise Of The Cannabis Beverage: An Analysis

‘The Black Swan’ Author Defends Fed And Banking System Amid SVB Collapse: ‘Technologists…Way Too Ignorant’

Oppenheimer Downgrades NeuBase Therapeutics to Perform